Skip to main content
OIDA Image Collection
Filters:
Reset 
A slide from a presentation about EXALGO a well-characterized safety profile. The slide has a white background with a map of Europe on the right side. On the left side there is a title that reads "EXALGO" in bold black font. Below the title there are three bullet points that explain the safety profile of the company.<br /><br />The first bullet point explains that the company has a wide-characterized safety profile with the following information:<br /><br />- Adverse reactions for EXALGEO are typical of other opioids:<br />- Most common adverse reactions (10% of the type of opioids)<br />- For complete list of adverse reactions see Full Prescription Information<br />- Reduced potential for certain drug interaction<br />- No active drug interactions<br /><br />There is also a note on the slide that states that no dose dumping<br />- Consuming alcohol does not significantly alter the release of EXALGO into the bloodstream. However patients should not consume alcohol while taking EXALGAO due to CNS depressive effect<br /><br />At the bottom of the slide there has a brief description of the safety features of the product including the additional important risk information including warning of the presence of full prescribing information.

Description Generated using AI

A slide from a presentation about EXALGO a well-characterized safety profile. The slide has a white background with a map of Europe on the right side. On the left side there is a title that reads "EXALGO" in bold black font. Below the title there are three bullet points that explain the safety profile of the company.

The first bullet point explains that the company has a wide-characterized safety profile with the following information:

- Adverse reactions for EXALGEO are typical of other opioids:
- Most common adverse reactions (10% of the type of opioids)
- For complete list of adverse reactions see Full Prescription Information
- Reduced potential for certain drug interaction
- No active drug interactions

There is also a note on the slide that states that no dose dumping
- Consuming alcohol does not significantly alter the release of EXALGO into the bloodstream. However patients should not consume alcohol while taking EXALGAO due to CNS depressive effect

At the bottom of the slide there has a brief description of the safety features of the product including the additional important risk information including warning of the presence of full prescribing information.

Type

Category

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Cite This Image

Information copied to your clipboard:

"A slide from a presentation about EXALGO a well-characterized safety profile. The slide has a white background with a map of Europe on the right side...